Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06181474Completed

MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease

Role: lead

NCT05890313Not ApplicableNot Yet Recruiting

Improving the Referral of Patients With Suspected Cognitive Impairment and Early Dementia

Role: collaborator

NCT05391646Not Yet Recruiting

Pulmonary Embolism Registry

Role: collaborator

NCT05315505Not ApplicableUnknown

Effectiveness of a Home-based Pulmonary Rehabilitation Program in COPD Patients

Role: lead

NCT04828941Not ApplicableUnknown

My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring

Role: lead

All 5 trials loaded